BioPorto Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BioPorto.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 30.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Feb 2024 |
Recent future growth updates
Recent updates
We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully
Dec 25We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully
Jun 28We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely
Feb 27Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth
Oct 19We're Keeping An Eye On BioPorto's (CPH:BIOPOR) Cash Burn Rate
Jun 15Is BioPorto (CPH:BIOPOR) In A Good Position To Deliver On Growth Plans?
Feb 17Here's Why We're Not Too Worried About BioPorto's (CPH:BIOPOR) Cash Burn Situation
Oct 16Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth
May 28BioPorto A/S' (CPH:BIOPOR) Path To Profitability
Mar 01We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully
Jan 24A Look At BioPorto's (CPH:BIOPOR) CEO Remuneration
Dec 20The BioPorto A/S (CPH:BIOPOR) Analysts Have Been Trimming Their Sales Forecasts
Nov 23BioPorto A/S (CPH:BIOPOR) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Nov 21In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BioPorto has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 40 | -38 | N/A | N/A | 1 |
3/31/2024 | 32 | -54 | -50 | -50 | N/A |
12/31/2023 | 31 | -56 | -55 | -55 | N/A |
9/30/2023 | 33 | -70 | -69 | -69 | N/A |
6/30/2023 | 30 | -78 | -63 | -63 | N/A |
3/31/2023 | 31 | -75 | -62 | -62 | N/A |
12/31/2022 | 29 | -76 | -53 | -52 | N/A |
9/30/2022 | 27 | -68 | -51 | -51 | N/A |
6/30/2022 | 27 | -62 | -59 | -58 | N/A |
3/31/2022 | 25 | -59 | -61 | -60 | N/A |
12/31/2021 | 24 | -57 | -65 | -65 | N/A |
9/30/2021 | 25 | -54 | -59 | -58 | N/A |
6/30/2021 | 24 | -60 | -48 | -47 | N/A |
3/31/2021 | 25 | -62 | -44 | -43 | N/A |
12/31/2020 | 23 | -62 | -37 | -36 | N/A |
9/30/2020 | 22 | -64 | -43 | -42 | N/A |
6/30/2020 | 24 | -68 | -55 | -55 | N/A |
3/31/2020 | 25 | -69 | -62 | -61 | N/A |
12/31/2019 | 27 | -70 | -61 | -60 | N/A |
9/30/2019 | 29 | -61 | -53 | -51 | N/A |
6/30/2019 | 28 | -51 | -45 | -44 | N/A |
3/31/2019 | 27 | -43 | -40 | -39 | N/A |
12/31/2018 | 26 | -38 | -39 | -38 | N/A |
9/30/2018 | 24 | -38 | -40 | -39 | N/A |
6/30/2018 | 25 | -36 | -38 | -38 | N/A |
3/31/2018 | 24 | -35 | -36 | -36 | N/A |
12/31/2017 | 25 | -32 | N/A | -29 | N/A |
9/30/2017 | 25 | -29 | N/A | -26 | N/A |
6/30/2017 | 23 | -27 | N/A | -25 | N/A |
3/31/2017 | 21 | -26 | N/A | -21 | N/A |
12/31/2016 | 21 | -23 | N/A | -20 | N/A |
9/30/2016 | 20 | -21 | N/A | -21 | N/A |
6/30/2016 | 20 | -16 | N/A | -20 | N/A |
3/31/2016 | 21 | -12 | N/A | -18 | N/A |
12/31/2015 | 20 | -11 | N/A | -17 | N/A |
9/30/2015 | 20 | -11 | N/A | -15 | N/A |
6/30/2015 | 19 | -12 | N/A | -14 | N/A |
3/31/2015 | 18 | -13 | N/A | -14 | N/A |
12/31/2014 | 19 | -13 | N/A | -16 | N/A |
9/30/2014 | 18 | -15 | N/A | -14 | N/A |
6/30/2014 | 19 | -19 | N/A | -16 | N/A |
3/31/2014 | 18 | -20 | N/A | -17 | N/A |
12/31/2013 | 17 | -22 | N/A | -17 | N/A |
9/30/2013 | 17 | -20 | N/A | -18 | N/A |
6/30/2013 | 16 | -17 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BIOPOR's forecast earnings growth is above the savings rate (0.9%).
Earnings vs Market: Insufficient data to determine if BIOPOR's earnings are forecast to grow faster than the Danish market
High Growth Earnings: Insufficient data to determine if BIOPOR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BIOPOR's revenue is forecast to grow faster than the Danish market.
High Growth Revenue: Insufficient data to determine if BIOPOR's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BIOPOR's Return on Equity is forecast to be high in 3 years time